Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection
- 20 October 1999
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 734 (1) , 55-61
- https://doi.org/10.1016/s0378-4347(99)00336-9
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- EfavirenzDrugs, 1998
- Calibration and validation of linearity in chromatographic biopharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 1991